Cross Country Healthcare (CCRN) Research Hub

Cross Country Healthcare (CCRN) trades on NASDAQ, US in the Industrials (Staffing & Employment Services) sector. As of 2026-07-20, shares last closed at 13.25 USD (+0.08%), in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. Valuation: trailing P/E -4.34, market cap 0.43B. This hub links to the full technical, earnings and options research available for CCRN.

Last updated 2026-07-20 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorIndustrials (Staffing & Employment Services)
ExchangeNASDAQ, US
Last close13.25 USD (+0.08%)
52-week range7.43 USD – 14.99 USD
Trend regimeUptrend
14-day RSI70 (Bullish)
Trailing P/E-4.34
Market cap0.43B
Dividend yield0.00%

Available research for CCRN

Earnings

CCRN earnings: real EPS beat/miss history, analyst consensus Hold, P/E -4.34. Updated 2026-07-23.

Options: Covered Call

Covered Call on CCRN: how it works, illustrative setup around the real 13.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on CCRN: how it works, illustrative setup around the real 13.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on CCRN: how it works, illustrative setup around the real 13.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

CCRN technical analysis: uptrend, last 13.25 USD, RSI 70, 52w range 7.43 USD–14.99 USD, real support/resistance. Updated 2026-07-20.

Frequently asked questions

What sector is CCRN in?

Cross Country Healthcare (CCRN) is classified under Industrials (Staffing & Employment Services), listed on NASDAQ, US.

Is CCRN in an uptrend or downtrend?

As of 2026-07-20, CCRN is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. See the full technical research page for support and resistance levels.

What is CCRN's trailing P/E ratio?

CCRN's trailing P/E is -4.34, with a market cap of 0.43B. See the earnings research page for full valuation detail.